ATE397459T1 - Sofort auflösbare medizinische zusammenstellung - Google Patents

Sofort auflösbare medizinische zusammenstellung

Info

Publication number
ATE397459T1
ATE397459T1 AT97950375T AT97950375T ATE397459T1 AT E397459 T1 ATE397459 T1 AT E397459T1 AT 97950375 T AT97950375 T AT 97950375T AT 97950375 T AT97950375 T AT 97950375T AT E397459 T1 ATE397459 T1 AT E397459T1
Authority
AT
Austria
Prior art keywords
medical composition
instantly dissolvable
instantly
dissolvable medical
composition
Prior art date
Application number
AT97950375T
Other languages
English (en)
Inventor
Hirokazu Takagi
Atsushi Kajiyama
Masahiro Yanagisawa
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Application granted granted Critical
Publication of ATE397459T1 publication Critical patent/ATE397459T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT97950375T 1996-12-25 1997-12-24 Sofort auflösbare medizinische zusammenstellung ATE397459T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP34476896 1996-12-25

Publications (1)

Publication Number Publication Date
ATE397459T1 true ATE397459T1 (de) 2008-06-15

Family

ID=18371833

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97950375T ATE397459T1 (de) 1996-12-25 1997-12-24 Sofort auflösbare medizinische zusammenstellung

Country Status (14)

Country Link
US (4) US20020031547A1 (de)
EP (2) EP1759712A2 (de)
JP (1) JP3988193B2 (de)
KR (1) KR100534504B1 (de)
CN (1) CN1132635C (de)
AR (1) AR009438A1 (de)
AT (1) ATE397459T1 (de)
AU (1) AU5339798A (de)
CA (1) CA2272586C (de)
DE (1) DE69738755D1 (de)
ES (1) ES2307303T3 (de)
TW (1) TW486370B (de)
WO (1) WO1998029137A1 (de)
ZA (1) ZA9711508B (de)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW486370B (en) * 1996-12-25 2002-05-11 Yamanouchi Pharma Co Ltd Rapidly disintegrable pharmaceutical composition
JP2000191518A (ja) * 1998-10-19 2000-07-11 Eisai Co Ltd 溶解性の改善された口腔内速崩壊性錠剤
DE19931708A1 (de) 1999-07-08 2001-01-18 Bayer Ag Verfahren zur Herstellung schnell zerfallender, fester pharmazeutischer Zubereitungen
AR028253A1 (es) 2000-03-16 2003-04-30 Pfizer Prod Inc Inhibidores de la glucogeno fosforilasa
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
CA2426263C (en) * 2000-10-24 2010-05-25 Ajinomoto Co., Inc. Nateglinide-containing preparation
EP1275377B1 (de) * 2001-07-11 2003-06-18 Apr Applied Pharma Research S.A. Fettlösliche Substanzen enthaltende Granulate und Verfahren zu ihrer Herstellung
RU2004123621A (ru) 2002-02-01 2005-04-10 Пфайзер Продактс Инк. (Us) Лекарственные формы с немедленным высвобождением, содержащие твердые дисперсии лекарств
US8377952B2 (en) * 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
CN100563658C (zh) * 2003-11-14 2009-12-02 味之素株式会社 苯丙氨酸衍生物的固体分散体或固体分散体医药制剂
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
ES2624585T3 (es) * 2004-05-28 2017-07-17 Imaginot Pty Ltd. Sistema de suministro de compuesto terapéutico oral
US20080031825A1 (en) * 2004-08-20 2008-02-07 Yisheng Chen Pharmaceutical Compositions Comprising Effervescent Agents And Fenofibrate
DE102005026755A1 (de) * 2005-06-09 2006-12-14 Basf Ag Herstellung von festen Lösungen schwerlöslicher Wirkstoffe durch Kurzzeitüberhitzung und schnelle Trocknung
KR101233235B1 (ko) * 2005-08-26 2013-02-15 에스케이케미칼주식회사 초기 용출율이 개선된 프란루카스트 고체분산체의 약제학적조성물 및 그의 제조방법
EP1938842A4 (de) * 2005-09-01 2013-01-09 Eisai R&D Man Co Ltd Verfahren zur herstellung einer pharmazeutischen zusammensetzung mit verbesserten zerfallseigenschaften
AU2006317530B2 (en) * 2005-11-28 2011-09-01 Imaginot Pty Ltd Oral therapeutic compound delivery system
CN101460154B (zh) 2006-04-04 2015-07-01 Kg艾克维泽生公司 包含抗血小板剂和抑酸剂的口服剂型
JP2007308479A (ja) * 2006-04-20 2007-11-29 Shin Etsu Chem Co Ltd 固体分散体製剤
WO2008064259A2 (en) * 2006-11-21 2008-05-29 Biokey, Inc. Solid dispersion composition comprising fluvastatin
ES2594433T3 (es) * 2008-04-02 2016-12-20 Astellas Pharma Inc. Composición farmacéutica que contiene derivado de amida
DE102009013611A1 (de) * 2009-03-17 2010-09-23 Ratiopharm Gmbh Festes Retigabin in nicht-kristalliner Form
US9724664B2 (en) * 2009-03-27 2017-08-08 Bend Research, Inc. Spray-drying process
US9125809B2 (en) * 2009-04-03 2015-09-08 Nichi-Iko Pharmaceutical Co., Ltd. Pectin-containing jelly formulation
CN101810563B (zh) * 2009-09-25 2012-04-25 宋洪涛 他克莫司眼用在体凝胶制剂及其制备方法
KR101422373B1 (ko) * 2009-11-19 2014-07-22 닛뽕소다 가부시키가이샤 밸러스트수의 환원 처리 방법
TWI564008B (zh) 2010-09-30 2017-01-01 鹽野義製藥股份有限公司 難溶性藥物之溶解性改善製劑
CN103313703A (zh) * 2010-12-27 2013-09-18 富田制药株式会社 制剂用崩解型核粒子
CA2828946C (en) 2011-04-18 2016-06-21 Eisai R&D Management Co., Ltd. Therapeutic agent for tumor
ES2841809T3 (es) 2011-06-03 2021-07-09 Eisai R&D Man Co Ltd Biomarcadores para pronosticar y evaluar el grado de respuesta de sujetos con cáncer de tiroides y de riñón a compuestos de lenvatinib
US20140024723A1 (en) * 2012-07-17 2014-01-23 Dow Global Technologies Llc Composition comprising an organic liquid diluent and a specific hydroxypropyl methylcellulose
EP3725778B1 (de) 2012-09-11 2021-08-18 Medivation Prostate Therapeutics LLC Formulierungen von enzalutamid
MX2015004979A (es) 2012-12-21 2015-07-17 Eisai R&D Man Co Ltd Forma amorfa de derivado de quinolina y metodo para su produccion.
AU2014266223B2 (en) 2013-05-14 2020-06-25 Eisai R&D Management Co., Ltd. Biomarkers for predicting and assessing responsiveness of endometrial cancer subjects to lenvatinib compounds
WO2015120014A1 (en) * 2014-02-05 2015-08-13 Merck Sharp & Dohme Corp. Novel disintegration systems for pharmaceutical dosage forms
WO2015119848A1 (en) 2014-02-05 2015-08-13 Merck Sharp & Dohme Corp. Tablet formulation for cgrp-active compounds
TW201613579A (en) 2014-06-24 2016-04-16 Astellas Pharma Inc Pharmaceutical composition for oral administration
ES2926687T3 (es) 2014-08-28 2022-10-27 Eisai R&D Man Co Ltd Derivado de quinolina muy puro y método para su producción
EP3212169B1 (de) 2014-10-31 2021-01-13 Bend Research, Inc. Verfahren zur herstellung von in einer matrix dispergierten aktiven domänen
HUE064614T2 (hu) 2015-02-25 2024-04-28 Eisai R&D Man Co Ltd Eljárás egy kinolin-származék keserû ízének elnyomására
KR102662228B1 (ko) 2015-03-04 2024-05-02 머크 샤프 앤드 돔 코포레이션 암을 치료하기 위한 pd-1 길항제 및 vegfr/fgfr/ret 티로신 키나제 억제제의 조합
WO2016175230A1 (ja) * 2015-04-28 2016-11-03 アステラス製薬株式会社 経口投与用医薬組成物
AU2016279474B2 (en) 2015-06-16 2021-09-09 Eisai R&D Management Co., Ltd. Anticancer agent
CA3036011A1 (en) 2016-08-20 2018-03-01 Ftf Pharma Private Limited Pharmaceutical composition comprising an androgen receptor inhibitor
EP3705118B1 (de) * 2017-10-31 2024-02-14 Samyang Holdings Corporation Zusammensetzung einer oralen festen darreichungsform mit verbesserter auflösung und verfahren zu ihrer herstellung
WO2019172420A1 (ja) * 2018-03-09 2019-09-12 協和発酵キリン株式会社 医薬組成物
CN112770750A (zh) * 2018-07-30 2021-05-07 中外制药株式会社 乙内酰脲衍生物的固体分散体
JP2022533463A (ja) 2019-05-23 2022-07-22 ヘルム・アクチエンゲゼルシャフト エンザルタミドを含むナノ粒子
IL295007A (en) 2020-01-31 2022-09-01 Nanocopoeia Llc Amorphous nilotinib microparticles and uses thereof
WO2021222739A1 (en) 2020-04-30 2021-11-04 Nanocopoeia, Llc Orally disintegrating tablet comprising amorphous solid dispersion of nilotinib

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
US4255413A (en) * 1979-10-01 1981-03-10 Smithkline Corporation Gelatin capsule dosage unit containing triamterene
JPS56110612A (en) * 1980-02-08 1981-09-01 Yamanouchi Pharmaceut Co Ltd Readily disintegrable and absorbable compression molded article of slightly soluble drug
JPS5948810A (ja) 1982-09-10 1984-03-21 Sony Corp 磁性記録体におけるデ−タのマスク及び再生方法
US4946686A (en) * 1987-09-24 1990-08-07 Merck & Co., Inc. Solubility modulated drug delivery system
EP0315964B1 (de) * 1987-11-11 1993-01-07 Laboratoires Pharmascience Exifon und ein wasserlösliches Polymer enthaltende pharmazeutische Zubereitung
US4964686A (en) * 1987-12-14 1990-10-23 Canon Kabushiki Kaishi Finder optical device
EP0379579A4 (en) * 1988-02-03 1991-01-02 Yoshitomi Pharmaceutical Industries, Ltd. Pharmaceutical composition having improved releasability
JP2814513B2 (ja) 1988-02-03 1998-10-22 吉富製薬株式会社 溶出性の改良された製剤組成物
US5211957A (en) * 1988-03-25 1993-05-18 Ciba-Geigy Corporation Solid rapidly disintegrating dosage form
JP2906528B2 (ja) * 1990-02-14 1999-06-21 大正製薬株式会社 吸収を促進した内服用固形製剤
JP3240729B2 (ja) * 1993-03-05 2001-12-25 株式会社リコー ファクシミリ装置
KR100340145B1 (ko) * 1993-08-26 2002-10-18 야마노우치세이야쿠 가부시키가이샤 벤즈아제핀유도체및이의중간체화합물
US5399358A (en) * 1993-11-12 1995-03-21 Edward Mendell Co., Inc. Sustained release formulations for 24 hour release of metroprolol
JPH08127533A (ja) * 1994-11-01 1996-05-21 Taisho Pharmaceut Co Ltd 内服固形製剤用組成物
WO1996019974A1 (fr) * 1994-12-27 1996-07-04 Kanebo, Ltd. Preparation a liberation prolongee
JPH08231403A (ja) * 1995-02-27 1996-09-10 Yamanouchi Pharmaceut Co Ltd アルギニンバソプレシン拮抗薬を含有する安定な水溶液
US5834472A (en) * 1996-05-24 1998-11-10 Schering Corporation Antifungal composition with enhanced bioavailability
TW486370B (en) * 1996-12-25 2002-05-11 Yamanouchi Pharma Co Ltd Rapidly disintegrable pharmaceutical composition
US5964686A (en) * 1997-11-07 1999-10-12 Griffin Automation, Inc. Method for forming slotted and creased box blanks
US6632455B2 (en) * 1997-12-22 2003-10-14 Schering Corporation Molecular dispersion composition with enhanced bioavailability

Also Published As

Publication number Publication date
AU5339798A (en) 1998-07-31
KR20000062327A (ko) 2000-10-25
ES2307303T3 (es) 2008-11-16
CN1241946A (zh) 2000-01-19
WO1998029137A1 (fr) 1998-07-09
US20020031547A1 (en) 2002-03-14
ZA9711508B (en) 1998-06-24
EP1008354B1 (de) 2008-06-04
US7189415B2 (en) 2007-03-13
CA2272586C (en) 2005-11-22
US20070014856A1 (en) 2007-01-18
US6899899B2 (en) 2005-05-31
CA2272586A1 (en) 1998-07-09
KR100534504B1 (ko) 2005-12-08
US20050095289A1 (en) 2005-05-05
DE69738755D1 (de) 2008-07-17
EP1008354A1 (de) 2000-06-14
JP3988193B2 (ja) 2007-10-10
EP1759712A2 (de) 2007-03-07
US20030003146A1 (en) 2003-01-02
CN1132635C (zh) 2003-12-31
EP1008354A4 (de) 2006-02-01
TW486370B (en) 2002-05-11
AR009438A1 (es) 2000-04-12

Similar Documents

Publication Publication Date Title
ATE397459T1 (de) Sofort auflösbare medizinische zusammenstellung
DE69727329D1 (de) Medizinische Elektrode
DE69731225D1 (de) Chirurgisches handstück
DE69734415D1 (de) SDH-Desynchronisierer
ATE328083T1 (de) Menschlicher bikunin
PT925083E (pt) Seringas
DE59704994D1 (de) Kombinationsinstrument
DE69721231D1 (de) Anisotrop leitende zusammensetzung
ID17860A (id) Komposisi vaksin
BR9705756A (pt) Escareador dentário
FI963154A0 (fi) Foerfarande foer upploesning av zinkslig under atmosfaeriska foer haollanden
DE69724334D1 (de) Endoskopeinheit
PT787861E (pt) Camisa
DE69704073T2 (de) Cmos-übertragungsleitungsentzerrer
DE59702387D1 (de) Medizinische zange
KR970004260U (ko) 정형외과용 콜셋
FI963434A0 (fi) Kraftoeverfoeringsanordning till rotationskolvmotor
KR970056542U (ko) 넥타이
FIU960047U0 (fi) Sarjalomake
FI2790U1 (fi) Tiivistelaippa
KR970050917U (ko) 개량 티슈케이스
KR970000143U (ko) 허리띠
FI960460A0 (fi) Laos
FI961085A0 (fi) Laos
FI961102A0 (fi) Foerfarande foer vidarebefordring av elektroniska postmeddelanden till en traodtelefonabonnent

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties